Alexandria Real Estate Equities, Inc. (ARE) Balance Sheet

The sequential decline in total assets, coupled with a drop in equity from $18.4B to $19.2B (though equity rose in 2026Q2 due to a liability reduction), indicates a shrinking footprint. The reduction in PPE net from $1.3B to zero by 2026Q2 is particularly notable, possibly reflecting a reclassification or impairment. This trajectory suggests management is actively recycling capital out of non-core assets, but the pace of contraction warrants monitoring for potential over-disposal.

The consistent decline in NOI, even as revenue contracted, suggests that occupancy or rental rates are softening, particularly in the Greater Boston cluster which is a key revenue driver. The high concentration in biotech tenants exposes ARE to the cyclicality of venture capital funding; a prolonged funding winter could pressure tenant retention and rent collections. Investors should monitor same-store NOI and leasing spreads for signs of stabilization.

The D/E ratio has crept up from 0.55 to 0.67 over the period, reflecting both higher debt and a slight decline in equity (excluding the 2026Q2 anomaly). With a large development pipeline, ARE likely relies on secured construction loans, which may carry floating rates. The absence of detailed maturity data limits assessment, but the rising leverage in a high-rate environment could pressure coverage ratios. The 2026Q2 data showing zero debt and PPE is likely a data artifact, but it obscures the true leverage picture.

The equity increase in 2026Q2 is driven by a reduction in total liabilities, not retained earnings, as net income has been negative in several quarters. The negative ROE, despite a large equity base, indicates that the company is not generating sufficient returns on its invested capital. This may be due to non-cash impairments or a temporary dip in FFO. The lack of secondary issuance data suggests ARE is not diluting shareholders, but the thin dividend coverage (payout ratio ~54% of FFO) leaves little room for error.

The shrinking cash balance, combined with volatile FFO (swinging from $703.8M in 2026Q1 to $230.7M in 2026Q2), suggests that ARE may be drawing down on its revolver to fund operations and development. The fixed charge coverage ratio is not disclosed, but with rising debt and interest rates, coverage may be tightening. The zero CapEx reported is implausible for a REIT with a large pipeline, implying that capital expenditures are being financed off-balance-sheet or classified elsewhere, which could mask true liquidity needs.

The absence of lease expiration schedules in the data limits analysis, but the revenue contraction suggests that lease rollovers are occurring at lower rents or that vacancies are rising. The development pipeline, while not quantified here, is a significant source of future supply; if pre-leasing slows due to biotech funding constraints, ARE may face higher vacancy and lower absorption. The negative net margins in recent quarters may indicate impairments on older properties, which could signal obsolescence risk and the need for costly redevelopment.